Press Releases

Debiopharm International SA Announces Results from Phase I Dose-Escalation Study of Debio 1347/CH5183284

GenePOC announces FDA clearance for revogene™ instrument and its GBS LB test

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case